> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Charging for Investigational Drugs
- URL: https://www.fdaweb.com/guidance-on-charging-for-investigational-drugs-2/
- Published: 2016-06-03T12:00:00.000Z
- Updated: 2026-09-14T21:07:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135837

*Federal Register* Notice: FDA has published a guidance on “Charging for Investigational Drugs Under an IND — Questions and Answers.” The document provides information on the implementation of the agency’s regulation on charging for investigational drugs for the purpose of either clinical trials or expanded access for treatment use. To view the guidance, click [here](http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM351264.pdf?ref=fdaweb.com). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-13166.pdf?ref=fdaweb.com).